Pamiparib
- CAS No.
- 1446261-44-4
- Chemical Name:
- Pamiparib
- Synonyms
- Pamiparib;bgb-290;EOS-61090;Pamiparib(BGB290);BGB-290,Pamiparib;Alflutinib Impurity 17;PAMIPARIB; BGB-290; BGB 290; BGB290.;inhibit,Pamiparib,PARP,Inhibitor,poly ADP ribose polymerase,BGB 290,BGB290;(R)-2-fluoro-10a-methyl-5,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(7H)-one;(R)-2-fluoro-10a-methyl-7,8,9,10,10a,11-hexahydro-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(5H)-one
- CBNumber:
- CB13137483
- Molecular Formula:
- C16H15FN4O
- Molecular Weight:
- 298.31
- MDL Number:
- MFCD30489383
- MOL File:
- 1446261-44-4.mol
Density | 1.68±0.1 g/cm3(Predicted) |
---|---|
storage temp. | Store at -20°C |
solubility |
DMF:20.0(Max Conc. mg/mL);67.04(Max Conc. mM) DMF:PBS (pH 7.2) (1:10):0.09(Max Conc. mg/mL);0.3(Max Conc. mM) DMSO:40.83(Max Conc. mg/mL);136.88(Max Conc. mM) Ethanol:45.0(Max Conc. mg/mL);150.84(Max Conc. mM) |
form | A solid |
pka | 11.56±0.40(Predicted) |
color | Light yellow to yellow |
FDA UNII | 8375F9S90C |
NCI Drug Dictionary | pamiparib |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS05,GHS06,GHS02 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Danger | |||||||||
Hazard statements | H300+H310+H330-H314-H226 | |||||||||
Precautionary statements | P501-P260-P270-P262-P240-P210-P233-P243-P241-P242-P271-P264-P280-P284-P370+P378-P361+P364-P303+P361+P353-P301+P330+P331-P301+P310+P330-P304+P340+P310-P305+P351+P338+P310-P403+P233-P403+P235-P405 | |||||||||
NFPA 704 |
|
Pamiparib price
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
ChemScene | CS-0027388 | Pamiparib 99.97% | 1446261-44-4 | 5mg | $90 | 2021-12-16 | Buy |
ChemScene | CS-0027388 | Pamiparib 99.97% | 1446261-44-4 | 10mg | $150 | 2021-12-16 | Buy |
ChemScene | CS-0027388 | Pamiparib 99.97% | 1446261-44-4 | 25mg | $250 | 2021-12-16 | Buy |
ChemScene | CS-0027388 | Pamiparib 99.97% | 1446261-44-4 | 50mg | $450 | 2021-12-16 | Buy |
ChemScene | CS-0027388 | Pamiparib 99.97% | 1446261-44-4 | 100mg | $750 | 2021-12-16 | Buy |
Pamiparib Chemical Properties,Uses,Production
Description
Pamiparib (BGB-290) is an investigational small molecule inhibitor of PARP1 and PARP2. Pamiparib is being evaluated as a monotherapy in pivotal clinical trials in China in recurrent platinum-sensitive and BRCA1/2 mutated ovarian cancers.
Uses
Pamiparib, is a PARP inhibitor, which can be used as an anticancer agent.
in vivo
Oral administration of Pamiparib results in time-dependent and dose-dependent inhibition of PARylation in MDA-MB-436 (BRCA1 mutant) breast cancer xenograft, correlating well with the tumor drug concentrations. It has also demonstrated good combination activity with chemotherapeutics in patient biopsy derived SCLC models. Also Pamiparib has significant brain penetration in C57 mice. The drug exposure in brain vs. that in plasma was close to 20% after oral administration of BGB-290.
Pamiparib Preparation Products And Raw materials
Pamiparib Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32070 | 58 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6312 | 58 |
Shenzhen Shengda Pharma Limited | 755-85269922 +8613424394241 | sales@shengdapharm.com | CHINA | 310 | 58 |
Zhejiang J&C Biological Technology Co.,Limited | +1-2135480471 +1-2135480471 | sales@sarms4muscle.com | China | 10473 | 58 |
InvivoChem | +1-708-310-1919 +1-13798911105 | sales@invivochem.cn | United States | 6391 | 58 |
LEAP CHEM CO., LTD. | +86-852-30606658 | market18@leapchem.com | China | 24727 | 58 |
Hangzhou MolCore BioPharmatech Co.,Ltd. | +86-057181025280; +8617767106207 | sales@molcore.com | China | 49734 | 58 |
TargetMol Chemicals Inc. | support@targetmol.com | United States | 38463 | 58 | |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | masar@topule.com | China | 8467 | 58 |